Positions

Principal Investigator On

Investigator On

  • 2/2- Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression  awarded by National Institute of Mental Health/NIH/DHHS
  • 2/4-A Genomic Approach to Schizophrenia  awarded by National Institute of Mental Health/NIH/DHHS
  • A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease (“Protocol”).  awarded by Washington University
  • A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease  awarded by Washington University
  • A Placebo-Controlled, Crossover Study of Fanapt® (iloperidone) Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL
  • AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer’s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer’s Disease and Intermediate Amyloid (A3 Trial)  awarded by University of Southern California
  • Alzehimer's Disease Neuroimaging Initiative (ADNI)  awarded by University of California, San Diego
  • Alzheimer's Disease Cooperative Study  awarded by University of California, San Diego
  • Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)  awarded by University of Southern California
  • Alzheimer's Disease Neuroimaging Initiative 3 (ADNl3)  awarded by University of Southern California
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study  awarded by University of Southern California
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)  awarded by University of Southern California
  • Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders with Treatment Resistant Depression (ASCERTAIN-TRD)  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE
  • Balanced Placebo Design with Varenicline: Pharmacological and Expectancy Effects on Medication Adherence  awarded by National Institute on Drug Abuse/NIH/DHHS
  • Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease  awarded by University of Southern California
  • Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL
  • Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)  awarded by MASSACHUSETTS GENERAL HOSPITAL
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - The LEARN Study A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of California, San Diego
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of Southern California
  • Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation  awarded by American Foundation for Suicide Prevention
  • Private Grant  awarded by JANSSEN AI (ALZHEIMER IMMUNOTHERAPY) R&D
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER
  • Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by NAUREX, INC.
  • Private Grant  awarded by Elan
  • Private Grant  awarded by TAL MEDICAL
  • Private Grant  awarded by INNOPHARMA, INC.
  • Private Grant  awarded by EISAI, INC.
  • Private Grant  awarded by H. LUNDBECK A/S
  • Private Grant  awarded by CERECOR, INC.
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by ASSUREX HEALTH INC.
  • Private Grant  awarded by H. LUNDBECK A/S
  • Private Grant  awarded by AVANIR PHARMACEUTICALS, INC.
  • Private Grant  awarded by ALKERMES, INC.
  • Private Grant  awarded by ALKERMES, INC.
  • Private Grant  awarded by NAUREX, INC.
  • Private Grant  awarded by FOREST LABORATORIES, INC.
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by BIOGEN, INC.
  • Private Grant  awarded by GENOMIND
  • Private Grant  awarded by ALLERGAN, INC.
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by Janssen
  • Private Grant  awarded by Janssen
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC.
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by ALLERGAN SALES, LLC
  • Private Grant  awarded by ALLERGAN SALES, LLC
  • Private Grant  awarded by ALLERGAN SALES, LLC
  • Private Grant  awarded by NEURORX
  • Private Grant  awarded by INTRA-CELLULAR THERAPIES INC.
  • Private Grant  awarded by ALLERGAN, INC.
  • Private Grant  awarded by BIOGEN, INC.
  • Private Grant  awarded by BIOGEN MA INC
  • Private Grant  awarded by Genentech
  • Private Grant  awarded by ALLERGAN, INC.
  • Private Grant  awarded by NAVITOR PHARMACEUTICALS INC.
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION - NEW
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC.
  • Private Grant  awarded by NEURORX
  • Private Grant  awarded by NEURORX
  • Private Grant  awarded by ACADIA PHARMACEUTICALS, INC.
  • Private Grant  awarded by BIOGEN MA INC
  • Private Grant  awarded by LIVANOVA USA, INC.
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^
  • Private Grant  awarded by AVANIR PHARMACEUTICALS, INC.
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease  awarded by University of Southern California
  • Education And Training

  • Master of Education, University of Alabama at Birmingham 1985
  • Bachelor's Degree in Mathematics, University of Alabama 1966
  • Full Name

  • Roberta May